CD4 and head and neck squamous cell carcinoma: HNSCC in BAAs also exhibited lower intratumoral infiltration of effector immune cells (including CD8+, resting memory CD4+ and activated memory CD4+ T cells) with shorter survival than in Whites [14], suggesting specific systemic therapeutic candidates for the treatment of BAA patients.